Boston Scientific (NYSE:BSX – Free Report) had its price target hoisted by UBS Group from $74.00 to $90.00 in a research note published on Thursday, Benzinga reports. They currently have a buy rating on the medical equipment provider’s stock. Several other brokerages also recently commented on BSX. BTIG Research reaffirmed a buy rating and set […]
Boston Scientific Co. (NYSE:BSX – Get Free Report)’s stock price reached a new 52-week high on Wednesday after Citigroup raised their price target on the stock from $79.00 to $85.00. Citigroup currently has a buy rating on the stock. Boston Scientific traded as high as $74.39 and last traded at $73.77, with a volume of […]
Boston Scientific (NYSE:BSX – Free Report) had its price target increased by UBS Group from $74.00 to $90.00 in a research report report published on Thursday, Benzinga reports. UBS Group currently has a buy rating on the medical equipment provider’s stock. BSX has been the subject of a number of other research reports. Wells Fargo […]
Boston Scientific (NYSE:BSX – Free Report) had its price target upped by Evercore ISI from $72.00 to $78.00 in a research report report published on Thursday, Benzinga reports. Evercore ISI currently has an outperform rating on the medical equipment provider’s stock. A number of other research analysts have also weighed in on BSX. Mizuho raised […]
Boston Scientific (NYSE:BSX – Get Free Report) had its price target increased by stock analysts at Barclays from $70.00 to $78.00 in a report issued on Friday, Benzinga reports. The firm currently has an “overweight” rating on the medical equipment provider’s stock. Barclays‘s target price would suggest a potential upside of 6.38% from the company’s […]